Leidos Holdings surged 5.48% intraday following the release of its Q3 2025 earnings report, which exceeded revenue and EPS estimates and included an upward revision of full-year guidance. The company reported $4.47 billion in revenue (beating estimates of $4.37 billion) and non-GAAP EPS of $3.05 (versus $2.77 expected), driven by strong performance across all four business segments, including organic growth in national security, health, and defense systems. Management cited strategic contract wins, including a $2.2 billion classified mission support contract, and a robust $47.7 billion backlog as key drivers. Analysts from Truist Financial and Cantor Fitzgerald reinforced a "Buy" rating post-earnings, aligning with the stock’s intraday rally. While pre-market trading initially dipped 1.06%, the positive earnings momentum and revised guidance likely attracted institutional buyers during regular hours.
Comments
No comments yet